An aggregate fee of $635.45 was paid with the filing of the Schedule TO-I by the Company (File No.005-90731) on November 26, 2021 (the “November 2021 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the November 2021 Schedule TO-I filed on February 16, 2022 was $439.04, as $4,736,138.63 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $635.45 filing fee paid in connection with the November 2021 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.
An aggregate fee of $1,359.69 was paid with the filing of the Schedule TO-I by the Company (File No.005-90731) on May 28, 2021 (the “May 2021 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the May 2021 Schedule TO-I filed on August 5, 2021 was $1,224.15, as $11,220,395.48 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,359.69 filing fee paid in connection with the May 2021 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.
An aggregate fee of $2,125.52 was paid with the filing of the Schedule TO-I by the Company (File No.005-90731) on February 26, 2021 (the “February 2021 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the February 2021 Schedule TO-I filed on May 10, 2021 was $1,206.85, as $11,061,880.89 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $2,125.52 filing fee paid in connection with the February 2021 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.
An aggregate fee of $1,528.95 was paid with the filing of the Schedule TO-I by the Company (File No.005-90731) on August 16, 2019 (the “August 2019 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the August 2019 Schedule TO-I filed on September 30, 2019 was $10.23, as $84,413.35 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,528.95 filing fee paid in connection with the August 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.
An aggregate fee of $1,532.03 was paid with the filing of the Schedule TO-I by the Company (File No.005-90731) on May 17, 2019 (the “May 2019 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the May 2019 Schedule TO-I filed on June 26, 2019 was $9.10, as $75,042.34 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,532.03 filing fee paid in connection with the May 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.
An aggregate fee of $1,522.81 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 22, 2019 (the “February 2019 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the February 2019 Schedule TO-I filed on March 27, 2019 was $8.81, as $72,667.54 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,522.81 filing fee paid in connection with the February 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.
An aggregate fee of $1,542.78 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on November 28, 2018 (the “November 2018 Schedule TO-I”). The final transaction fee due pursuant to the final amendment to the November 2018 Schedule TO-I filed on December 28, 2018 was $8.26, as $68,121.91 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,542.78 filing fee paid in connection with the November 2018 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.